Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 579INDUSTRY 131NIH 124NETWORK 58OTHER_GOV 5FED 2UNKNOWN 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1

Conditions

Prostatic Neoplasms 17Rare Diseases 3Neoplasms 3Neoplasm Metastasis 3Leukemia 3Recurrence 2Lymphoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Genetic Diseases, Inborn 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Squamous Cell 2Adenocarcinoma Of Esophagus 2Turcot syndrome 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Respiratory Aspiration 1Radiation Pneumonitis 1Prostate Cancer Diagnosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Non-Muscle Invasive Bladder Neoplasms 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neuroma, Acoustic 1Neurologic Manifestations 1Neurofibromatosis 2 1Neurofibromatoses 1

Interventions

zanubrutinib 1venetoclax 1ibrutinib 1acalabrutinib 1Topotecan 1Mitoxantrone 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × FED × Lymphoma × Clear all
NCT06520098 2025-10-14

Benefit VA

VA Office of Research and Development

Phase 2 Recruiting
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00100477 2013-09-25

Use of Topotecan in Patients With Refractory Acute Leukemia

VA Office of Research and Development

Phase 2 Completed
10 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡